PROTO SCRIPT PHARMACEUTICAL CORP. (OTCMKTS:PSCR) Files An 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim ReviewItem 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.
On October 4, 2017, Proto Script Pharmaceutical Corp. (the “Company”) was notified from its registered public accounting firm (the “Auditor”) that the Auditor had provided the Company with consent to file the Company’s Form 10-K for the fiscal year ended December 31, 2016 which the Company previously filed with the Commission on September 20, 2017, prior to receiving final consent to file by the Auditor’s EQR Partner.
About PROTO SCRIPT PHARMACEUTICAL CORP. (OTCMKTS:PSCR)
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company’s health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.